✦ LIBER ✦

Chemotherapy for patients with advanced prostate carcinoma : A new option for therapy

✍ Scribed by William K. Oh

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 130 KB
Volume: 88
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20000615)88:12+<3015::aid-cncr18>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormone therapy for patients with prosta

Hormone therapy for patients with prostate carcinoma

✍ Laurence Klotz 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

Early results of a prospective study of

Early results of a prospective study of hormone therapy for patients with locally advanced prostate carcinoma

✍ Jackson E. Fowler Jr.; Steven A. Bigler; John M. Kolski; David T. Yee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Background: Locally advanced prostate carcinoma is usually not curable with surgery or radiation therapy. primary hormone therapy is an alternative therapeutic option, but contemporary prospective studies of the outcomes of such therapy are not available. ## Methods: The authors conducted a pr

Chemotherapy for patients with locally a

Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma

✍ Eric Voog; Pierre Biron; Jean-Pierre Martin; Jean-Yves Blay 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## BACKGROUND. Merkel cell carcinoma (MCC) is a highly malignant skin neoplasm. Regional lymph node and distant metastasis occur in 20 -52% of patients. The role of chemotherapy in the treatment of patients with this rare tumor is unclear. METHODS. An exhaustive analysis of the literature (1980

Mitoxantrone in patients with prostate s

Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma

✍ Robert S. DiPaola; Eric S. Chenven; Weichung J. Shih; Yong Lin; Peter Amenta; Su 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB 👁 2 views

A new option for the “no-option” patient

A new option for the “no-option” patient with refractory angina?

✍ Timothy D. Henry 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Suramin in combination with weekly epiru

Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma

✍ Alfredo Falcone; Andrea Antonuzzo; Romano Danesi; Giacomo Allegrini; Lencioni Mo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## BACKGROUND. Suramin and epirubicin are both active agents in the treatment of patients with hormone-refractory advanced prostate carcinoma, with demonstrated antitumor synergism in vitro on human prostate carcinoma cells and different dose-limiting toxicities. The authors conducted this Phase I